WOEXT: 91 - Drug
 
Bib -> Asymmetry | Author | ICA | NMF | Novelty | Statistics | SVD | Title | WOBIB ]
 
 
Exp -> Alphabetic | Asymmetry | ICA | NMF | Novelty | SVD | WOEXP | WOEXT ]
 
 
Ext -> Alphabetic index | Map | Roots ]          [ Brede ]          Loc -> Statistics ]
 


WOEXT: 91. Drug.


ParentsSiblingsChildren
  Nitroglycerin
Capsaicin
Dobutamine
Histamine
Bupivacaine
Analgesics
Placebo
Serotonin reuptake inhibitor
Vinpocetine
Histamine H1 Antagonist
Acetylcholinesterase inhibitor
Ketamine

Experiments:

No experiments

Child experiments:

  1. Left handgrip due to anesthesia. 1Hz Rythmic left handgrip. WOEXP: 49.
    M. Nowak; K. S. Olsen; I. Law; Sĝren Holm; O. B. Paulson; N. H. Secher. Command-related distribution of regional cerebral blood flow during attempted handgrip. Journal of Applied Physiology 86(3):819-824, 1999. PMID: 10066691. WOBIB: 16.
  2. Fentanyl during heat and warm stimulus on left arm. Fentanyl administration during 40 degrees Celsius warmth or 47-48 degrees hot pain on the volar forearm versus placebo with stimulus. WOEXP: 316.
    L. J. Adler; F. E. Gyulai; D. J. Diehl; M. A. Mintun; P. M. Winter; L. L. Firestone. Regional brain activity changes associated with fentanyl analgesia elucidated by positron emission tomography. Anesthesia & Analgesia 84(1):120-126, 1997. PMID: 8989012. WOBIB: 101.
  3. Placebo during heat and warm stimulus on left arm. Placebo administration during 40 degrees Celsius warmth or 47-48 degrees hot pain on the volar forearm versus fentanyl with stimulus. WOEXP: 317.
    L. J. Adler; F. E. Gyulai; D. J. Diehl; M. A. Mintun; P. M. Winter; L. L. Firestone. Regional brain activity changes associated with fentanyl analgesia elucidated by positron emission tomography. Anesthesia & Analgesia 84(1):120-126, 1997. PMID: 8989012. WOBIB: 101.
  4. Decrease in obsessive-compulsive disorder patients after treatment with paroxetine. Decrease in obsessive-compulsive disorder patients after treatment with paroxetine. WOEXP: 387.
    Elsebet S. Hansen; Steen Hasselbalch; Ian Law; Tom G. Bolwig. The caudate nucleus in obsessive-compulsive disorder. Reduced metabolism following treatment with paroxetine: a PET study. International Journal of Neuropsychopharmacology 5(1):1-10, 2002. PMID: 12057027. DOI: doi:10.1017/S1461145701002681. WOBIB: 125.
  5. Obsessive-compulsive disorder severity. Correlation with obsessive-compulsive disorder severity in patients before and after treatment with paroxetine. WOEXP: 388.
    Elsebet S. Hansen; Steen Hasselbalch; Ian Law; Tom G. Bolwig. The caudate nucleus in obsessive-compulsive disorder. Reduced metabolism following treatment with paroxetine: a PET study. International Journal of Neuropsychopharmacology 5(1):1-10, 2002. PMID: 12057027. DOI: doi:10.1017/S1461145701002681. WOBIB: 125.
  6. Binding potential of doxepin after ebastine compared to after chlorpheniramine. Binding potential of doxepin on histamine H1 receptor after administering of 10 mg of ebatine versus binding potential after administring of 2 mg of (+)-chlorpheniramine. WOEXP: 392.
    M. Tagawa; M. Kano; N. Okamura; M. Higuchi; M. Matsuda; Y. Mizuki; H. Arai; R. Iwata; T. Fujii; S. Komemushi; T. Ido; M. Itoh; H. Sasaki; T. Watanabe; K. Yanai. Neuroimaging of histamine H1-receptor occupancy in human brain by positron emission tomography (PET): a comparative study of ebastine, a second-generation antihistamine, and (+)-chlorpheniramine, a classical antihistamine. British Journal of Clinical Pharmacology 52(5):501-509, 2001. PMID: 11736858. WOBIB: 127.
  7. Nitroglycerin-provoked cluster headache. Nitroglycerin-provoked acute headache in cluster headache patients versus pain-free state. WOEXP: 424.
    Arne May; Anish Bahra; Christian Büchel; Richard S. J. Frackowiak; Peter J. Goadsby. Hypothalamic activation in cluster headache attacks. Lancet 352(9124):275-278, 1998. PMID: 9690407. FMRIDCID: . WOBIB: 137.
  8. Positive age-citalopram dependence. Positive correlation with age of 40mg citalopram administration. WOEXP: 425.
    Sara Goldberg; Gwenn S. Smith; Anna Barnes; Yilong Ma; Elisse Kramer; Kimberly Robeson; Margaret Kirshner; Bruce G. Pollock; David Eidelberg. Serotonin modulation of cerebral glucose metabolism in normal aging. Neurobiology of Aging 25(2):167-174, 2004. PMID: 14749134. FMRIDCID: . WOBIB: 138.
  9. Fearful face recognition with placebo drug. Fearful face recognition after placebo infusion versus neutral face recognition after placebo infusion. WOEXP: 475.
    Kathryn M. Abel; Matthew P. G. Allin; Katarzyna Kucharska-Pietura; Anthony S. David; Chris Andrew; Steven C. R. Williams; Michael J. Brammer; Mary L. Phillips. Ketamine alters neural processing of facial emotion recognition in healthy men: an fMRI study. NeuroReport 14(3):387-391, 2003. PMID: 12634489. DOI: 10.1097/01.wnr.0000058031.29600.31. FMRIDCID: . WOBIB: 155.
  10. Neutral face recognition versus fearful with placebo drug. Neutral face recognition after placebo infusion versus fearful face recognition after placebo infusion. WOEXP: 476.
    Kathryn M. Abel; Matthew P. G. Allin; Katarzyna Kucharska-Pietura; Anthony S. David; Chris Andrew; Steven C. R. Williams; Michael J. Brammer; Mary L. Phillips. Ketamine alters neural processing of facial emotion recognition in healthy men: an fMRI study. NeuroReport 14(3):387-391, 2003. PMID: 12634489. DOI: 10.1097/01.wnr.0000058031.29600.31. FMRIDCID: . WOBIB: 155.
  11. Fearful face recognition with ketamine drug. Fearful face recognition after ketamine-induced emotional blunting versus neutral face recognition after ketamine infusion. WOEXP: 477.
    Kathryn M. Abel; Matthew P. G. Allin; Katarzyna Kucharska-Pietura; Anthony S. David; Chris Andrew; Steven C. R. Williams; Michael J. Brammer; Mary L. Phillips. Ketamine alters neural processing of facial emotion recognition in healthy men: an fMRI study. NeuroReport 14(3):387-391, 2003. PMID: 12634489. DOI: 10.1097/01.wnr.0000058031.29600.31. FMRIDCID: . WOBIB: 155.
  12. Neutral face recognition versus fearful with ketamine drug. Neutral face recognition after ketamine-induced emotional blunting versus fearful face recognition after ketamine infusion. WOEXP: 478.
    Kathryn M. Abel; Matthew P. G. Allin; Katarzyna Kucharska-Pietura; Anthony S. David; Chris Andrew; Steven C. R. Williams; Michael J. Brammer; Mary L. Phillips. Ketamine alters neural processing of facial emotion recognition in healthy men: an fMRI study. NeuroReport 14(3):387-391, 2003. PMID: 12634489. DOI: 10.1097/01.wnr.0000058031.29600.31. FMRIDCID: . WOBIB: 155.
  13. Fearful face recognition with placebo drug versus with ketamine. Fearful face recognition after placebo infusion versus neutral face recognition after placebo infusion and fearful face recognition with ketamine. WOEXP: 479.
    Kathryn M. Abel; Matthew P. G. Allin; Katarzyna Kucharska-Pietura; Anthony S. David; Chris Andrew; Steven C. R. Williams; Michael J. Brammer; Mary L. Phillips. Ketamine alters neural processing of facial emotion recognition in healthy men: an fMRI study. NeuroReport 14(3):387-391, 2003. PMID: 12634489. DOI: 10.1097/01.wnr.0000058031.29600.31. FMRIDCID: . WOBIB: 155.
  14. Neutral face recognition with ketamine versus fearful with placebo drug. Neutral face recognition after ketamine-induced emotional blunting versus with placebo infusion and fearful face recognition after ketamine infusion. WOEXP: 480.
    Kathryn M. Abel; Matthew P. G. Allin; Katarzyna Kucharska-Pietura; Anthony S. David; Chris Andrew; Steven C. R. Williams; Michael J. Brammer; Mary L. Phillips. Ketamine alters neural processing of facial emotion recognition in healthy men: an fMRI study. NeuroReport 14(3):387-391, 2003. PMID: 12634489. DOI: 10.1097/01.wnr.0000058031.29600.31. FMRIDCID: . WOBIB: 155.
Corner cube


Bib -> Asymmetry | Author | ICA | NMF | Novelty | Statistics | SVD | Title | WOBIB ]
Exp -> Alphabetic | Asymmetry | ICA | NMF | Novelty | SVD | WOEXP | WOEXT ]
Ext -> Alphabetic index | Map | Roots ]          [ Brede ]          Loc -> Statistics ]
Automatically constructed by Brede Toolbox through brede_ext_ext2html, 2006-08-15T21:53:15